Screening patients at high-risk for lung cancer more likely when prmary care provider is familiar with guidelines

Results of more than 200 primary care providers indicate knowledge gap

2014-10-30

(Press-News.org) Chicago, October 30, 2014—Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. The Symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and The University of Chicago Medicine.

Lung cancer is the second most commonly occurring cancer and the leading cause of cancer-related death for both men and women in the United States. The use of LDCT screening for high-risk individuals has been recommended by several national health care organizations including the American Lung Association, the American College of Chest Physicians and the U.S. Preventive Services Task Force (USPSTF). High-risk patients, according to the December 2013 "Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement," include adults aged 55 to 80 years, who have a 30 pack-year smoking history and who currently smoke or have quit within the past 15 years. Research has demonstrated that LDCT screening can lead to earlier diagnosis of lung cancer thereby reducing lung cancer-specific mortality by 16 percent and increasing overall survival.

An online survey was sent to 488 primary care providers, including physicians, physician assistants and nurse practitioners, affiliated with the Wake Forest Baptist Medical Center in North Carolina, to identify their knowledge of, practice of and attitudes about lung cancer screening. The survey measured the provider's use of lung cancer screening tests in the past year; the perceived effectiveness of LDCT screening in reducing lung cancer-specific mortality; knowledge of LDCT consensus guidelines; perceived barriers to LDCT screening; and interest in further education about LDCT screening for lung cancer.

Sixty percent (293) of the primary care providers responded. Of those respondents, 212 primary care providers cared for patients older than age 40 in the past year and were eligible for the study. Twenty-one percent (45) of respondents ordered a chest X-ray for lung cancer screening, and 12 percent (25) recommended LDCT for lung cancer screening, with an additional 3 percent (6) ordering sputum cytology (analysis of mucus from the lungs and airways).

The survey results showed that 48 percent (102) of respondents knew three or more of the six guideline components for LDCT screening, including who to screen, the recommended screening intervals and when to start or stop screening. Twenty-four percent (51) of providers that responded did not know any of the guideline components. Logistic regression analysis determined if providers' knowledge of national guidelines influenced LDCT utilization. Providers who knew three or more of the guideline components were more likely to order LDCT screening for individuals at high-risk for developing lung cancer (Odds Ratio 5.0, 95 percent 1.9-12.9). Eighty percent (170) of the primary care providers responded that they were interested in more education about lung cancer screening.

Of the eligible respondents, 30 percent (64) were unsure of the effectiveness of LDCT in reducing cancer mortality, and none of these providers recommended LDCT for lung cancer screening for their patients.

The most commonly perceived barriers to LDCT screening according to survey respondents were patient cost (87 percent, n=184); potential harm from false positive findings (83 percent, n=176); patients' lack of awareness (81 percent, n=172); potential harm from incidental findings (81 percent, n=172); and no insurance coverage (80 percent, n=170).

"The results of this survey highlight an essential need for provider education on the effectiveness of low-dose CT screening for lung cancer, on lung cancer screening guideline recommendations and the potential benefits and harms of screening," said Jennifer Lewis, MD, lead study author and an assistant chief of medicine in the Department of Internal Medicine at Wake Forest Baptist in Winston-Salem, North Carolina. "It is also important to provide additional education for patients so that they can participate with their primary care provider in making informed decisions about lung cancer screening."

The abstract, "Low-dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center," will be presented in detail during a scientific session at 8:00 a.m. Central time on Thursday, October 30, 2014.

INFORMATION:

To speak with Dr. Lewis, please call Michelle Kirkwood. The 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology will provide a clinically relevant, multidisciplinary update on the scientific progress in treating thoracic malignancies. The symposium brings together physician specialists and practicing clinicians of the multidisciplinary care team to discuss the evolving management of thoracic cancers. The Symposium integrates scientific abstract presentations with accompanying discussions, poster abstract presentations, as well as "challenging case" presentations in interactive tumor board-style forums. The two keynote speakers for the Symposium are Kenneth Rosenzwieg, MD, FASTRO, of Mount Sinai School of Medicine in New York, and Corey J. Langer, MD, of Abramson Cancer Center in Philadelphia. Dr. Rosenzwieg will discuss the use of mutational analysis to guide systemic therapy; and Dr. Langer will review the cutting edge, lung cancer research presented at recent national meetings – ASCO, ASTRO and STS (Society of Thoracic Surgeons).

2014 Chicago Multidisciplinary Symposium in Thoracic Oncology News Briefing, Thursday, October 30, 2014, 7:00 a.m. Central time

Scientific Session: Thursday, October 30, 2014, 8:00 – 9:30 a.m. CT, Grand Ballroom I-III, Chicago Marriott Downtown Magnificent Mile

13 Low-dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center

Author Block: J. Lewis, W. J. Petty, J. A. Tooze, D. P. Miller, C. Chiles, A. A. Miller, K. E. Weaver, Wake Forest School of Medicine, Winston-Salem, NC

Purpose/Objective(s): Low-dose computed tomography (LDCT) screening reduces lung cancer-specific and overall mortality. National organizations endorse LDCT, but successful implementation depends on referrals by primary care providers (PCPs). We sought to assess lung cancer screening use and potential barriers of LDCT use among PCPs.

Materials/Methods: In late 2013, we sent an online survey to all PCPs at a large academic medical center. The survey assessed: use of lung cancer screening tests in the past year; perceived effectiveness of LDCT screening in reducing lung cancer-specific mortality; knowledge of LDCT consensus guidelines (screen annually, begin age 50 or 55, end age 74, 20 or 30 pack years, current and former smokers, not second-hand smoke only); perceived barriers to LDCT screening; and interest in further education about LDCT. We used logistic regression to examine if guideline knowledge predicted LDCT utilization. Ratings of LDCT as very or moderately effective compared to perceived effectiveness of other screening modalities were compared using McNemar's test.

Results: The response rate was 60% (293/488); eligible responders included 212 who provided primary care to patients > age 40 in the preceding year. Few PCP's reported ordering lung cancer screening examinations, including chest x-ray (21%), LDCT (12%), and sputum cytology (3%). Almost one-half (48%) of providers knew ≥3 of 6 guideline components for LDCT screening; 24% did not know any guideline components. Providers who knew > 3 guideline components were more likely to order LDCT (OR 5.0, 95% 1.9-12.9). Many providers (30%) were unsure of the effectiveness of LDCT in reducing cancer mortality; none of these providers had ordered LDCT. More PCPs rated mammography, colonoscopy, and Pap smear as very or moderately effective than they did LDCT (all p-values < 0.0001). The most commonly perceived barriers to LDCT screening were patient cost (87% major or minor barrier), potential harm from false positive findings (83%), patients' lack of awareness (81%), potential harm from incidental findings (81%), and no insurance coverage (80%). Most PCPs (80%) were interested in further lung cancer screening education.

Conclusions: LDCT lung cancer screening is an uncommon practice at an academic medical center despite guideline recommendations. Furthermore, PCPs report ordering chest x-ray, a non-recommended screening test, more often than LDCT. Cost, potential harm, and patients' lack of knowledge were the most commonly perceived barriers. However, PCP knowledge of LDCT guidelines was strongly associated with ordering LDCT. Educational interventions are critical to increasing LDCT screening and should specifically address effectiveness, guideline recommendations, cost, and potential harms.

Author Disclosure Block: J. Lewis: None. W.J. Petty: None. J.A. Tooze: None. D.P. Miller: None. C. Chiles: None. A.A. Miller: None. K.E. Weaver: None.

ELSE PRESS RELEASES FROM THIS DATE:

Reef-builders with a sense of harmony

2014-10-30

They live in the cold, dark depths of the oceans, are often exposed to strong currents and provide a stable base for diverse and colourful ecosystems: Stony corals of the species Lophelia pertusa are considered excellent reef-builders. According to the latest findings of researchers from the Heriot-Watt University Edinburgh, GEOMAR Helmholtz Centre for Ocean Research Kiel, the University of Glasgow and the United States Geological Survey, even genetically different individuals are able to fuse their skeletons. On an expedition with the German submersible JAGO and the research ...

Peripheral clocks don't need the brain's master clock to function correctly

2014-10-30

Circadian clocks regulate functions ranging from alertness and reaction time to body temperature and blood pressure. New research published in the November 2014 issue of The FASEB Journal further adds to our understanding of the circadian rhythm by suggesting that the suprachiasmaticus nucleus (SCN) clock, a tiny region of the hypothalamus considered to be the body's "master" timekeeper, is not necessary to align body rhythms with the light-dark cycle. This challenges and disproves the commonly held notion that circadian rhythms were strictly organized in a hierarchical ...

BPA exposure by infants may increase later risk of food intolerance

2014-10-30

If it seems like more people are allergic to, or intolerant of, more and different kinds of foods than ever before, there might be a reason why. A new research published in November 2014 issue of The FASEB Journal, scientists show, for the first time, that there is a link between perinatal exposure to Bisphenol A (BPA) at low doses and the risk to develop food intolerance in later life. This research involving rats suggests that early life exposure at a dose significantly below the current human safety limit set by the FDA affects developing immune systems, predisposing ...

Disney Research develops hybrid fluid transmission enabling light and swift robotic arms

2014-10-30

Engineers routinely face tradeoffs as they design robotic limbs – weight vs. speed, ease of control vs. fluidity. A new hybrid fluid transmission developed at Disney Research Pittsburgh promises to eliminate some of those tradeoffs, making possible robot arms that are light enough to move swiftly and gracefully, yet with precise control. The transmission consists of antagonist pairs of rolling diaphragm cylinders – similar to traditional hydraulic cylinders, but sealed with a rubber diaphragm instead of sliding seals and valves. The result is a system that ...

Size matters: Baby's size at birth may predict risk for disease later in life

2014-10-30

A new research report published in the November 2014 issue of The FASEB Journal suggests that being overweight might be better in the long term than being underweight. Before you reach for that box of Twinkies, however, it's important to note that this discovery only applies to the weight of newborn babies in relation to risk of future disease. "These findings support the hypothesis that common long-term variation in the activity of genes established in the womb may underpin links between size at birth and risk for adult disease," said Claire R. Quilter, Ph.D., study ...

New molecule sneaks medicines across the blood/brain barrier

2014-10-30

Delivering life-saving drugs across the blood-brain barrier (BBB) might become a little easier thanks to a new report published in the November 2014 issue of The FASEB Journal. In the report, scientists describe an antibody, called "FC5," is one-tenth the size of a traditional antibody and able to cross the BBB. Moreover, FC5 uses the same pathways as nutrients that the brain needs to survive, allowing it to "smuggle" larger antibodies across the barrier. Like a Lego building block, FC5 connects into many types of antibody designs, helping them reach their disease targets ...

Clock gene dysregulation may explain overactive bladder

2014-10-30

If you think sleep problems and bladder problems are a fact of life in old age, you may be right. A new report appearing in the November 2014 issue of The FASEB Journal, shows that our sleep-wake cycles are genetically connected to our bladder, and disruptions to one may cause problems with the other. This discovery builds on the hypotheses that under normal circumstances, a primary clock located in the brain controls several other peripheral clocks located throughout the body. These peripheral clocks, in turn, control the activity of functional proteins and receptors, ...

Patents for humanity: Special edition of Technology and Innovation

2014-10-30

TAMPA, Fla. (Oct. 30, 2014) – The current special issue of Technology and Innovation, is devoted to patents that benefit people around the world who live with limited resources, in challenging environments, and are in need of better access to basic needs and improved standards of living, health and infrastructure. The issue includes original articles from winners of the 2013 USPTO Patents for Humanity Awards, aimed at rewarding innovators for deploying patented technologies to address humanitarian needs. Winners featured in the issue include SIGN Fracture Care International, ...

Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

2014-10-30

LOS ANGELES (Oct. 29, 2014) – Lou Gehrig's disease, also known as amyotrophic lateral sclerosis, or ALS, attacks muscle-controlling nerve cells – motor neurons – in the brain, brainstem and spinal cord, leading to progressive weakness and eventual paralysis of muscles throughout the body. Patients typically survive only three to five years after diagnosis. Now, with publication of a study by investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute, ALS researchers know the effects of the attack are worsened, at least in part, ...

Smithsonian scientist discovers populations of rare songbird in surprising new habitat

2014-10-30

The Swainson's warbler (Limnothlypis swainsonii) is one of the rarest and most secretive songbirds in North America, prized by birdwatchers in the southeastern U.S. hoping to catch a glimpse of it in the wild or hear its beautiful ringing song. With only 90,000 breeding individuals sparsely distributed across 15 states in the U.S., the Swainson's warbler is a species of high conservation concern that, for decades, has left conservationists with little confidence that its populations would ever be fully secure. However, new research published in the Oct. 30 edition of ...